Globus Medical (GMED)
Net profit margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 122,873 | 190,169 | 149,191 | 102,285 | 155,210 |
Revenue | US$ in thousands | 1,568,480 | 1,022,840 | 958,102 | 789,042 | 785,368 |
Net profit margin | 7.83% | 18.59% | 15.57% | 12.96% | 19.76% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $122,873K ÷ $1,568,480K
= 7.83%
The net profit margin of Globus Medical Inc has shown fluctuating trends over the past five years, ranging from 12.96% in 2020 to 19.76% in 2019. The margin decreased to 15.57% in 2021 before further declining to 18.59% in 2022 and significantly dropping to 7.83% in 2023. This downward trend may indicate challenges in maintaining profitability or controlling costs. Further investigation into the company's financial performance and operational efficiency is recommended to understand the factors contributing to the variations in the net profit margin.
Peer comparison
Dec 31, 2023
Company name
Symbol
Net profit margin
Globus Medical
GMED
7.83%
3M Company
MMM
-21.40%
Artivion Inc
AORT
-9.27%
Baxter International Inc
BAX
17.89%
Becton Dickinson and Company
BDX
7.66%
Boston Scientific Corp
BSX
11.38%
DexCom Inc
DXCM
15.03%
Embecta Corp
EMBC
6.33%
Glaukos Corp
GKOS
-44.71%
Haemonetics Corporation
HAE
4.53%
ICU Medical Inc
ICUI
-1.31%